Middle East Pharmaceutical Industries Co. (4016.SR)

SAR 120.2

(-0.5%)

Market Cap (In SAR)

2.4 Billion

Revenue (In SAR)

338.43 Million

Net Income (In SAR)

65.82 Million

Avg. Volume

122.59 Thousand

Currency
SAR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-197.6
PE
-
EPS
-
Beta Value
0.0
ISIN
SA160G51UO10
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mohamed Maher MohammedLotfi Alghannam
Employee Count
-
Website
-
Ipo Date
2024-02-27
Details
Middle East Pharmaceutical Industries Company researches, develops, manufactures, and markets generic medicines and pharmaceuticals in the Kingdom of Saudi Arabia. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medications; disinfectants and sterilizers; and various therapeutic medicines and preparations, including sexual system medicines, diabetes, cardiovascular medicines, anti-infective medicines, anti-parasitic medicines, pain relievers, antiseptics, and women's and men's health medicines in form of creams, dispensers, gels, hand sanitizers, lubricating gels, mouthwashes, soaps, solutions, sprays, surgical scrubs, tablets, and vaginal douches. The company also provides contract manufacturing services. In addition, it exports its products. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. The company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.

More Stocks